Learning objectives
To analyze imaging characteristics of retroperitoneal tumors in several modalities with histopathological verification, and follow-up of the lesions.
To identify the imaging findings that are most important for anatomic localization and preoperative characterization.
Background
The retroperitoneal space is one of the most difficult regions to evaluate due to the multiplicity of fascial layers, spaces and interfascial planes contained within it.Diagnostic imaging is the cornerstone of retroperitoneal tumors and is often challenging for radiologists (locating the lesion, determining the extent of invasion, characterizing the type of pathology). CT and MRI are the primary imaging modalities for the diagnosis and follow up of these lesions.We conducted a single-center, retrospective, observational study at the National Cancer institute of Mexico from January 2016...
Findings and procedure details
Retroperitoneal sarcomas (RPS) are a rare type of malignancy derived from primitive multipotential mesenchymal precursors. They represent <1% of all malignant tumors(1). Overall incidence is 0.3%–0.4% per 100000 of the population(2), with peak incidence in the 5th decade of life (3). They can grow very large before producing any symptoms or can also be incidental findings.
The most frequent RPS in adults (>55years) are well differentiated liposarcoma(WDL), de-differentiated liposarcoma(DDL) (40%) and leiomyosarcoma(LMS) (27%). In younger age groups LMS becomes more common(4,5).
In our sample of...
Conclusion
The radiologist plays an important role in establishing the diagnosis, defining the extension and anatomical relationship of retroperitoneal tumors, performing image-guided biopsy, staging the tumor, assessing the feasibility of curative surgery and to detect early recurrences. According to our experience, CT is the most useful and widely available imaging modality in staging, restaging and follow up of these tumors. This article briefly summarizes the key features of the most common RPS in the general population; in the same way, it warns us of potential problems...
Personal information and conflict of interest
J. L. VILLALOBOS FRANCO:
Nothing to disclose
D. J. Roa Melo:
Nothing to disclose
M. J. Sarda:
Nothing to disclose
D. García Ortega:
Nothing to disclose
C. H. S. Sánchez- Caro:
Nothing to disclose
I. S. Sollozo-Dupont:
Nothing to disclose
Y. Villaseñor:
Nothing to disclose
References
Mack T, Purgina B. Updates in Pathology for Retroperitoneal Soft Tissue Sarcoma. Current Oncology [Internet]. 2022 Sep 7 [cited 2023 Feb 14];29(9):6400–18. Available from: https://www.mdpi.com/1718-7729/29/9/504
Mettlin C, Priore R, Rao U, Gamble D, Lane W, Murphy GP. Results of the national soft-tissue sarcoma registry. J Surg Oncol [Internet]. 1982 Apr [cited 2023 Feb 14];19(4):224–7. Available from: https://onlinelibrary.wiley.com/doi/10.1002/jso.2930190410
Francis IR. Retroperitoneal sarcomas. Cancer Imaging [Internet]. 2005 [cited 2023 Feb 14];5(1):89–94. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1665230/
Bonvalot S, Gronchi A, Hohenberger P, Litiere S, Pollock RE, Raut CP, et...